References
- 1. BOLAKI M, ANTONIOU KM. Combined Pulmonary Fibrosis and Emphysema. Semin Respir Crit Care Med 2020; 41(2): 17–183.
- 2. HAGE R, GAUTSCHI F, STEINACK C, SCHUURMANS MM. Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management. Int J Chron Obstruct Pulmon Dis 2021; 16: 167–77.
- 3. KOO BS, PARK KY, LEE HJ, KIM HJ, AHN HS, YIM SY, et al. Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis. Arthritis Res Ther 2021; 23(1): 100.
- 4. COTTIN V, NUNES H, MOUTHON L, GAMONDES D, LAZOR R, HACHULLA E, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63(1): 295–304.
- 5. HAMAGUCHI Y, FUJIMOTO M, MATSUSHITA T, KAJI K, KOMURA K, HASEGAWA M, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-t-RNA synthetase antibodies: heterogeneity within the syndrome. PLoS One 2013; 8: e60442.
- 6. KOREEDA Y, HIGASHIMOTO I, YAMAMOTO M, TAKAHASHI M, KAJI K, FUJIMOTO M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010; 49(5): 361–9.
- 7. DAIDO W, YAMASAKI M, MORIO Y, FUNAISHI K, ISHIYAMA S, DEGUCHI N, et al. A rare combination of dermatomyositis, IP, and lung cancer in a patient treated with immunosuppressive therapy and chemotherapy. Intern Med. 2018; 57(6): 849–53.
- 8. TARGOFF IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20(4): 857–80.
- 9. MARGUERIE C, BUNN CC, BEYNON HL, BERNSTEIN RM, HUGHES JM, SO AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77(282): 1019–38.
- 10. LOVE LA, LEFF RL, FRASER DD, TARGOFF IN, DALAKAS M, PLOTZ PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70(6): 360–74.
- 11. HIRAKATA M, NAGAI S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000; 12(6): 501–8.
- 12. YOKOI E, HARUTA Y, WADA Y, ITO H, MACHIDA K, MATSUO M. Three cases of interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies complicated by gynecological cancer. Nihon Kokyuuki Gakkai Zassi 2018: 7(4): 229–32 (in Japanese).
- 13. SHIKANO K, KANEKO K, KABURAKI K, ISOBE K, KAWABE K, HOMMA S, et al. Nivolumab-induced anti-aminoacyltRNA synthetase antibody-positive polymyositis complicated by interstitial pneumonia in a patient with lung adenocarcinoma. Scand J Rheumatol 2020; 49(1): 82–83.
- 14. FUJITA Y, HIRANO S, YONESHIM Y, IZUMI S, TAKEDA Y, SUGIYAMA H, et al. A case of acute exacerbation of interstitial pneumonia complicated with dermatomyositis during treatment for lung cancer, and literature review. Nihon Kokyuki Gakkai Zasshi 2011; 49(2): 108–15 (in Japanese).